Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen M Brensinger

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Medicina (Kaunas, Lithuania)|September 23, 2022
Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle RelaxantsCharles E Leonard, Colleen M Brensinger, Warren B Bilker, et al.
Cardiovascular Diabetology|February 27, 2020
The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safetyCharles E Leonard, Colleen M Brensinger, Ghadeer K Dawwas, et al.
International Journal of Behavioral Medicine|July 7, 2009
Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinicsDean G Cruess, A Russell Localio, Alec B Platt, et al.
British Journal of Clinical Pharmacology|May 13, 2022
Skeletal muscle relaxant drug-drug-drug interactions and unintentional traumatic injury: Screening to detect three-way drug interaction signalsCheng Chen, Sean Hennessy, Colleen M Brensinger, et al.
JAMA Dermatology|October 29, 2015
Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin CancerFrank I Scott, Ronac Mamtani, Colleen M Brensinger, et al.
Clinical Pharmacology and Therapeutics|July 26, 2022
Identifying Clinically Relevant Drug-Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal DetectionTodd A Miano, Lei Wang, Charles E Leonard, et al.
Journal of Psychiatric Research|May 8, 2022
Population-based signals of benzodiazepine drug interactions associated with unintentional traumatic injuryThanh Phuong Pham Nguyen, Samantha E Soprano, Sean Hennessy, et al.
Pharmacoepidemiology and Drug Safety|February 14, 2008
Risk factors for nonadherence to warfarin: results from the IN-RANGE studyAlec B Platt, A Russell Localio, Colleen M Brensinger, et al.
Chest|November 12, 2009
Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) StudyAlec B Platt, A Russell Localio, Colleen M Brensinger, et al.
Crohn'S & Colitis 360|June 23, 2023
Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus TofacitinibMichael D Kappelman, Millie D Long, Xian Zhang, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Medicina (Kaunas, Lithuania)|September 23, 2022
Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle RelaxantsCharles E Leonard, Colleen M Brensinger, Warren B Bilker, et al.
Cardiovascular Diabetology|February 27, 2020
The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safetyCharles E Leonard, Colleen M Brensinger, Ghadeer K Dawwas, et al.
International Journal of Behavioral Medicine|July 7, 2009
Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinicsDean G Cruess, A Russell Localio, Alec B Platt, et al.
British Journal of Clinical Pharmacology|May 13, 2022
Skeletal muscle relaxant drug-drug-drug interactions and unintentional traumatic injury: Screening to detect three-way drug interaction signalsCheng Chen, Sean Hennessy, Colleen M Brensinger, et al.
JAMA Dermatology|October 29, 2015
Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin CancerFrank I Scott, Ronac Mamtani, Colleen M Brensinger, et al.
Clinical Pharmacology and Therapeutics|July 26, 2022
Identifying Clinically Relevant Drug-Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal DetectionTodd A Miano, Lei Wang, Charles E Leonard, et al.
Journal of Psychiatric Research|May 8, 2022
Population-based signals of benzodiazepine drug interactions associated with unintentional traumatic injuryThanh Phuong Pham Nguyen, Samantha E Soprano, Sean Hennessy, et al.
Pharmacoepidemiology and Drug Safety|February 14, 2008
Risk factors for nonadherence to warfarin: results from the IN-RANGE studyAlec B Platt, A Russell Localio, Colleen M Brensinger, et al.
Chest|November 12, 2009
Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) StudyAlec B Platt, A Russell Localio, Colleen M Brensinger, et al.
Crohn'S & Colitis 360|June 23, 2023
Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus TofacitinibMichael D Kappelman, Millie D Long, Xian Zhang, et al.
Pageof 12